Trademark: 87836342
Word
CURARAD
Status
Registered
Status Code
700
Status Date
Tuesday, April 30, 2019
Serial Number
87836342
Registration Number
5741258
Registration Date
Tuesday, April 30, 2019
Mark Type
4
Filing Date
Thursday, March 15, 2018
Published for Opposition
Tuesday, August 21, 2018

Trademark Owner History
KEYAMED NA INC. -
CuraCloud Corporation - Original Registrant

Classifications
42 Providing software as a service (SaaS) services featuring software for use in medical diagnostics, medical image analysis, medical screening, medical testing, DNA screening for medical purposes, and genetic testing for medical purposes; providing software as a service (SaaS) services featuring software for the analysis of medical data, namely, medical imaging data, health care data, health records, medical records, and genomic data for use in the prevention, diagnosis and treatment of medical conditions, analyzing clinical trials, analyzing drug interactions, development of vaccines and medicines, analyzing medical diagnostic data, analyzing molecular medicine data, analyzing precision medicine data, and structural and functional analysis of genomes; providing software as a service (SaaS) services featuring software for the analysis of genomic data for use in tracking variation and mutation of pathogens; providing software as a service (SaaS) services featuring software for determining and predicting patterns in data, namely, medical data, genomic data, proteomic data, metabolomics data, transcriptomic data, nutritional and nutrigenomics data, medical imaging data, health care data, health records, medical records, genomic data, and environmental factor data; providing software as a service (SaaS) services featuring software for executing preconfigured non-field specific machine learning and deep learning algorithms and processes for the purposes of uploading and managing data for the training of preconfigured data models implemented on a hosted software platform utilizing said machine learning and deep learning processes and for utilizing said trained data models for use in medical diagnostics, medical image analysis, medical screening, medical testing, DNA screening for medical purposes, and genetic testing for medical purposes; providing software as a service (SaaS) services featuring software for conducting natural language processing on medical records to transform unstructured data into structured data supporting clinical and research use; research, development, testing, and deployment of immunotherapy drugs all being pharmaceutical drug development services; Platform as a service (PaaS) featuring computer software platforms for providing clinical decision support for patient care; providing scientific analysis in the field of next generation sequencing (NGS), namely, the analysis and interpretation of genomic data

Trademark Events
Mar 22, 2018
New Application Office Supplied Data Entered
Jul 2, 2018
Examiner's Amendment Entered
Mar 19, 2018
New Application Entered
Jun 26, 2018
Assigned To Examiner
Jul 2, 2018
Examiners Amendment -Written
Jul 2, 2018
Examiners Amendment E-Mailed
Jul 2, 2018
Notification Of Examiners Amendment E-Mailed
Jul 2, 2018
Approved For Pub - Principal Register
Aug 1, 2018
Notification Of Notice Of Publication E-Mailed
Feb 28, 2019
Teas Statement Of Use Received
Mar 20, 2019
Case Assigned To Intent To Use Paralegal
Jul 16, 2018
Assigned To Lie
Aug 21, 2018
Published For Opposition
Aug 21, 2018
Official Gazette Publication Confirmation E-Mailed
Oct 16, 2018
Noa E-Mailed - Sou Required From Applicant
Feb 28, 2019
Use Amendment Filed
Mar 22, 2019
Statement Of Use Processing Complete
Mar 28, 2019
Notice Of Acceptance Of Statement Of Use E-Mailed
Apr 30, 2019
Registered-Principal Register
Apr 30, 2024
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Feb 24, 2021
Automatic Update Of Assignment Of Ownership
Mar 27, 2019
Allowed Principal Register - Sou Accepted

Trademark Alertz updated from USPTO on 2030-01-24